Skip to main content

Advertisement

SpringerLink
Log in

De-escalation of breast cancer treatment for Her2-positive breast cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Enquiries about data availability should be directed to the authors.

References

  1. Ali S, Hendry J, Le D, Mondal PK, Sami A, Chalchal H, Haider K, Ahmed O, El-Gayed A, Wright P, Pauls M, Johnson K, Ahmed S (2022) Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study. Sci Rep 12(1):1068. https://doi.org/10.1038/s41598-022-05209-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Crook T, Leonard R, Mokbel K, Thompson A, Michell M, Page R, Vaid A, Mehrotra R, Ranade A, Limaye S, Patil D, Akolkar D, Datta V, Fulmali P, Apurwa S, Schuster S, Srinivasan A, Datar R (2022) Accurate screening for early-stage breast cancer by detection and profiling of circulating tumor cells. Cancers (Basel) 14(14):3341. https://doi.org/10.3390/cancers14143341

    Article  CAS  Google Scholar 

  3. Groen EJ, van der Noordaa MEM, Schaapveld M, Sonke GS, Mann RM, van Ramshorst MS, Lips EH, VranckenPeeters MTFD, van Duijnhoven FH, Wesseling J (2021) Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer. Breast Cancer Res Treat 189(1):213–224. https://doi.org/10.1007/s10549-021-06235-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

  1. The London Breast Institute, Princess Grace Hospital, London, W1U 5NY, UK

    Parinita Swarnkar & Kefah Mokbel

  2. Latymer Upper School, London, UK

    Lara Mokbel

Authors
  1. Parinita Swarnkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lara Mokbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kefah Mokbel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parinita Swarnkar.

Ethics declarations

Conflict of Interest

The authors have not disclosed any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Swarnkar, P., Mokbel, L. & Mokbel, K. De-escalation of breast cancer treatment for Her2-positive breast cancer. Breast Cancer Res Treat 196, 243–244 (2022). https://doi.org/10.1007/s10549-022-06737-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-022-06737-7

Search

Navigation